WATER: A Double‐Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia
暂无分享,去创建一个
C. Roehrborn | M. Desai | G. Badlani | P. Gilling | A. Te | R. Kaufman | T. Aho | Mark S. DeGuenther | N. Barber | E. Kramolowsky | L. Doumanian | B. Cowan | M. Bidair | Paul Anderson | M. Sutton | A. Thomas | A. Trainer | A. Arther | M. Plante
[1] C. Gratzke,et al. [One-year randomized controlled trial outcomes after aquablation and transurthral resection of the prostate for the treatment of lower urinary tract symptoms]. , 2019, Der Urologe. Ausg. A.
[2] C. Roehrborn,et al. How I do it: Balloon tamponade of prostatic fossa following Aquablation. , 2017, The Canadian journal of urology.
[3] P. Gilling,et al. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1‐Year Results , 2017, The Journal of urology.
[4] C. Roehrborn,et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. , 2017, The Canadian journal of urology.
[5] J. Kim,et al. Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis , 2017, PloS one.
[6] Arman Kahokehr,et al. Aquablation – image‐guided robot‐assisted waterjet ablation of the prostate: initial clinical experience , 2016, BJU international.
[7] C. Roehrborn,et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. , 2016, The Journal of urology.
[8] Z. Meng,et al. Holmium Laser Enucleation versus Transurethral Resection in Patients with Benign Prostate Hyperplasia: An Updated Systematic Review with Meta-Analysis and Trial Sequential Analysis , 2014, PloS one.
[9] F. Bruyère,et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. , 2014, European urology.
[10] A. Araujo,et al. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. , 2011, European urology.
[11] John T. Wei,et al. Update on AUA guideline on the management of benign prostatic hyperplasia. , 2011, The Journal of urology.
[12] U. Nagele,et al. Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection , 2011, World Journal of Urology.
[13] R. Miano,et al. Treatment options for benign prostatic hyperplasia in older men. , 2008, Medical science monitor : international medical journal of experimental and clinical research.
[14] F. Montorsi,et al. Safety and Tolerability of Treatment for BPH , 2006 .
[15] Rainer Hofmann,et al. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. , 2006, European urology.
[16] J. Catania,et al. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. , 2005, Urology.
[17] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[18] K. McVary,et al. Transurethral microwave thermotherapy for benign prostatic hyperplasia. , 2003, International braz j urol : official journal of the Brazilian Society of Urology.
[19] U. Engelmann,et al. MICROWAVE THERMOTHERAPY FOR BENIGN PROSTATIC HYPERPLASIA WITH THE DORNIER UROWAVE , 1999 .
[20] Marberger,et al. Is transurethral resection of the prostate still justified? , 1999, BJU international.
[21] H. Sandvik,et al. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. , 1993, Journal of epidemiology and community health.
[22] A. Zbrozek,et al. The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument , 1993, PharmacoEconomics.
[23] J. Oesterling,et al. The prevalence of prostatism: a population-based survey of urinary symptoms. , 1993, The Journal of urology.
[24] M. Barry,et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.
[25] M Nurminen,et al. Comparative analysis of two rates. , 1985, Statistics in medicine.
[26] D. N. Papachristou,et al. Resection of the liver with a water jet , 1982, The British journal of surgery.
[27] C. Roehrborn. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. , 2008, Reviews in urology.
[28] I. Miyazaki,et al. Hepatic resection using a water jet dissector , 2004, Surgery Today.
[29] AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. , 2003, The Journal of urology.
[30] G. Maddern,et al. Hepatic Resection Using a Water Jet Dissector , 1993, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.
[31] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .